Portfolio company
Amylyx Pharmaceuticals
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This biotechnology company develops pharmaceutical therapies for people with neurodegenerative and endocrine disorders, including amyotrophic lateral sclerosis and post-bariatric hypoglycemia.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Yumanity Therapeutics
This company develops small molecule drugs to treat neurodegenerative diseases for patients with conditions such as Parkinson's disease and amyotrophic lateral sclerosis.
QurAlis
This company develops precision medicines for patients with amyotrophic lateral sclerosis, frontotemporal dementia, and other neurodegenerative diseases.
NeurOdys Therapeutics
This biotechnology company develops small molecule therapies for patients with neurodegenerative conditions such as Alzheimer's and Parkinson's diseases.
AMYL THERAPEUTICS
The company develops pan-amyloid immunotherapies to treat patients with neurodegenerative and rare diseases caused by toxic protein aggregates.
Crucible Therapeutics
This biotechnology company develops RNA-based therapies for patients with neurodegenerative conditions such as amyotrophic lateral sclerosis and frontotemporal dementia.
Alector
This biopharmaceutical company develops therapies for neurodegenerative diseases using a blood-brain barrier delivery platform for patients with conditions including ALS and Parkinson’s.
Eikonoklastes Therapeutics
This clinical stage biopharmaceutical company develops gene therapies for patients suffering from amyotrophic lateral sclerosis and other neurodegenerative diseases.
CuraSen Therapeutics
This biopharmaceutical company develops small molecule drugs to treat patients with neurodegenerative disorders, such as Parkinson's and Alzheimer's disease.